Notably, the favorable response of TFEBS142A cells to PLX4720 was abolished when cells were treated with BafA1 or depleted of Beclin1, suggesting that TFEB-induced autophagy–lysosomal activation is required to elicit a response to BRAFi in melanoma (Supplementary Fig. 10c). This evidence concerns the gene TFEB and melanoma.